Population
Patients with chronic kidney disease
Design
Review
Authors
Loading...
Supports stiffness-targeted strategies in CKD CV risk; leaves open prospective trials of calcification-reducing therapies.
Increased arterial stiffness is a key driver of the high cardiovascular burden in chronic kidney disease, highlighting the need for targeted therapeutic strategies such as specific antihypertensives and reduction of vascular calcification.
Gusbeth–Tatomir et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: